We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 09 MAY 2012
Supreme Court Allows Generic Manufacturers To Challenge Overbroad Use Codes
Fenwick
The United States Supreme Court has again reversed the Federal Circuit, ruling unanimously that a generic drug manufacturer may file a counterclaim to force correction of an overbroad use code that encompasses unclaimed methods of using the drug at issue.
United StatesIntellectual Property










